Role of protein kinase G in nitric oxide deficiency-induced supersensitivity to nitrovasodilator in rat pulmonary artery

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 5, 2008, Pages 450-456

  Gupta, Praveen K ^a   Subramani, Jaganathan ^a   Singh, Thakur Uttam ^a   Leo, Marie Dennis Marcus ^a   Sikarwar, Anurag S ^a   Prakash, Vellanki Ravi ^a   Mishra, Santosh K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

CGMP; G kinase; Nitrovasodilator; NO deficiency; Pulmonary artery; Supersensitivity

Indexed keywords

8 BROMO CYCLIC GMP; BUCLADESINE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT; 8-BROMOCYCLIC GMP; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; VASODILATATION; ANIMAL; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MUSCLE RELAXATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ANIMALS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; PULMONARY ARTERY; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 55949123752     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31816949ca     Document Type: Article

References (26)

1. Archer SL, Huang JM, Hampl V, et al. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA. 1994;91: 7583-7587.
2. Stamler JS, Loh E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994; 89:2035-2040.
3. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
4. Leiper J, Nandi M, Torondel B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007;13: 198-203.
5. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991;338:1173-1174.
6. Evgenov OV, Ichinose F, Evgenov NV, et al. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs. Circulation. 2004;110:2253-2259.
7. Boer C, Groeneveld AB, Scheffer GJ, et al. Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed rat pulmonary arteries. J Surg Res. 2005;127:197-202.
8. Dinerman JL, Lawson DL, Mehta JL. Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol Heart Circ Physiol. 1991;260:H698-H701.
9. Moncada S, Rees DD, Schulz R, et al. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA. 1991;88:2166-2170.
10. Rees DD, Palmer RM, Hodson HF, et al. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
11. da Cunha V, Rossoni LV, Oliveira PA, et al. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats. Clin Exp Hypertens. 2000;22:203-215.
12. Hussain MB, Hobbs AJ, MacAllister RJ. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta. Br J Pharmacol. 1999;128:1082-1088.
13. Brandes RP, Kim D, Schmitz-Winnenthal FH, et al. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension. 2000;35: 231-236.
14. Mullershausen F, Russwurm M, Koesling D, et al. The enhanced NO-induced cGMP response induced by long-term L-NAME treatment is not due to enhanced expression of NO-sensitive guanylyl cyclase. Vasc Pharmacol. 2003;40:161-165.
15. Gao Y, Dhanakoti S, Trevino EM, et al. Role of cGMP-dependent protein kinase in development of tolerance to nitric oxide in pulmonary veins of newborn lambs. Am J Physiol Lung Cell Mol Physiol. 2004;286:L786-L792.
16. Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with folin protein reagent. J Biol Chem. 1951; 193:265-275.
17. Chen G, Suzuki H, Weston AH. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol. 1988;95:1165-1174.
18. Karamsetty MR, Nakashima JM, Ou LC, et al. EDHF contributes to strain-related differences in pulmonary arterial relaxation in rats. Am J Physiol Lung Cell Mol Physiol. 2001;280:L458-L464.
19. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits rhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem. 2000;275:21722-21729.
20. Zhao YJ, Wang J, Rubin LJ, et al. Inhibition of Kv and KCa channels antagonizes NO-induced relaxation in pulmonary artery. Am J Physiol Heart Circ Physiol. 1997;272:H904-H912.
21. Haynes J Jr, Robinson J, Saunders L, et al. Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation. Am J Physiol Heart Circ Physiol. 1992;262:H511-H516.
22. Eckly-Michel A, Martin V, Lugnier C. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br J Pharmacol. 1997;122:158-164.
23. Ca channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase. Am J Physiol Lung Cell Mol Physiol. 2003;284:L1004-L1011.
24. Kwak YA, Jones KA, Warner DO, et al. NO responsiveness in pulmonary artery and airway smooth muscle: the role of cGMP regulation. Am J Physiol Lung Cell Mol Physiol. 2006;290:L200-L208.
25. Lucas KA, Pitari GM, Kazerounian S, et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 2000;52:375-414.
26. Kinoshita H, Iwahashi S, Kakutani T, et al. The role of endothelium-derived nitric oxide in relaxations to levcromakalim in the rat aorta. Jpn J Pharmacol. 1999;81:362-366.